Venus Medtech (Hangzhou) Inc.: Confirmatory clinical trial o

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen

Related Keywords

Mao Chen , Shaanxi , China , Dalian , Liaoning , Qingdao , Shandong , Japan , Zhongshan , Anhui , United States , Yun Zhang , Zhejiang , Shanxi , Fujian , Guangdong , Jilin , Hangzhou , Sichuan , Gansu , Zhengzhou , Henan , Dennis Riedl , Eric Zi , Liwen Liu , Venus Medtech , Venus Medtech Hangzhou Inc , Xiamen Cardiovascular Hospital University , Sichuan University , Qilu Hospital Of Shandong University , Fudan University , University Of Health , Hangzhou Nuocheng Medical Technology Co Ltd , First Affiliated Hospital Of Dalian Medical University , National Medical Products Administration , Zhejiang University School Of Medicine , China Hospital Sichuan University , Rehabilitation Sciences Qingdao Hospital , West China Hospital , Professor Liwen Liu , First Affiliated Hospital , Air Force Medical University , Zhongshan Hospital , Qilu Hospital , Shandong University , Second Affiliated Hospital , Zhejiang University School , West China Hospital Sichuan University , Guangdong Provincial People , Qingdao Municipal Hospital , Dalian Medical University , Shanxi Cardiovascular , Special Approval Procedures , Innovative Medical Devices , Liwen Procedure , Air Force Medical , Outstanding Innovation Award , First Prize , Technological Progress Award , Executive Director , General Manager , Bristol Myers Squibb , Venus , Edtech , Confirmatory , Linical , Trial , Liwen , Tablation , System , Oncluded ,